Ho Maykin

Ho Maykin is listed in filings as Director at Biomarin Pharmaceutical Inc. This profile follows SEC Form 4 activity through Jun 4, 2026, including 18 public disclosures. Recent filings connect the profile to Biomarin Pharmaceutical Inc (BMRN), Neumora Therapeutics, Inc. Common Stock (NMRA), Agios Pharmaceuticals, Inc. - Common Stock (AGIO) (AGIO), and Kyntra Bio, Inc. (KYNB). The current snapshot covers public activity from Feb 18, 2025 to Jun 4, 2026. Reported amounts are shown as $148.8K to $36.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.